| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/27/2008 | WO2008036069A2 A particle counting and dna uptake system and method for detection, assessment and further analysis of threats due to nebulized biological agents |
| 03/27/2008 | WO2008036060A2 Clostridial toxin activity assays |
| 03/27/2008 | WO2008035881A1 Method and apparatus for detecting bio-chip by using phase-change |
| 03/27/2008 | WO2008035748A1 Blood analysis apparatus |
| 03/27/2008 | WO2008035729A1 Method of searching for ligand |
| 03/27/2008 | WO2008035697A1 Blood sensor and blood examining instrument including same |
| 03/27/2008 | WO2008035692A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 03/27/2008 | WO2008035569A1 Biomolecule detection reagent and biomolecule detection method using the reagent |
| 03/27/2008 | WO2008035565A1 Biomolecule detection reagent and biomolecule detection method using the same |
| 03/27/2008 | WO2008035527A1 ANTI-C1q MONOCLONAL ANTIBODY |
| 03/27/2008 | WO2008035309A2 Method for identifying compounds that act as insulin-sensitizers |
| 03/27/2008 | WO2008035252A2 A sensor device for and a method of sensing particles |
| 03/27/2008 | WO2008035096A1 Assay |
| 03/27/2008 | WO2008035080A1 Optical sorting |
| 03/27/2008 | WO2008035073A2 Method of detecting interactions on a microarray using nuclear magnetic resonance |
| 03/27/2008 | WO2008035047A1 Blood typing |
| 03/27/2008 | WO2008034946A1 Method and device for monitoring the condition of a medium |
| 03/27/2008 | WO2008034907A1 Immobilisation of fluorescent proteins |
| 03/27/2008 | WO2008034906A1 Method of detection |
| 03/27/2008 | WO2008034750A1 Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization |
| 03/27/2008 | WO2008034645A1 Digestive system cancer stem cells and tests and uses therefor |
| 03/27/2008 | WO2008034637A1 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases |
| 03/27/2008 | WO2008034621A2 Nucleotide phosphorylase for the prophylaxis, treatment or diagnosis of acute lung injury (ali) |
| 03/27/2008 | WO2008034587A1 Determination of hydrogen peroxide concentrations |
| 03/27/2008 | WO2008034332A1 Method for observing cells, chip and device |
| 03/27/2008 | WO2008034297A1 Method of detecting antibodies against a series of human immunodeficiency virus proteins |
| 03/27/2008 | WO2008034275A1 Coating for microcarriers |
| 03/27/2008 | WO2008012093A3 Method and arrangement for determining the yarn quality and/or spool quality of a running thread based on laser-doppler anemometry |
| 03/27/2008 | WO2008011881A3 Thermocatalytic hydrocarbon measurment device for detecting leaks in submarine pipelines |
| 03/27/2008 | WO2008005877A3 Inhibitors of c-kit and uses thereof |
| 03/27/2008 | WO2008001116A3 A method for the presumptive detection of substances |
| 03/27/2008 | WO2008000070B1 Glycyrrhetinic acid derivatives |
| 03/27/2008 | WO2007149550A3 Modulation of differentiation and cell function via fox01 and notch signaling |
| 03/27/2008 | WO2007148106A3 Detection of acetylation of prokaryotic proteins by mass spectrometry |
| 03/27/2008 | WO2007147971A3 Method for evaluating the degree of dilution of oil by a radioactivity measurement |
| 03/27/2008 | WO2007147497A3 Use of a disintegrin-like and metalloproteinase with thrombospondin type 1 motif (adamts1) as a therapeutic or diagnostic target |
| 03/27/2008 | WO2007140599A8 Assessment of risk for colorectal cancer |
| 03/27/2008 | WO2007135570A3 Pink1 deficient animals, screening methods, and related therapeutics |
| 03/27/2008 | WO2007133456A3 Test sensor with under-fill protection |
| 03/27/2008 | WO2007132366A3 Microelectronic sensor device for concentration measurements |
| 03/27/2008 | WO2007132179A3 Therapeutics comprising pyridinium derivatives |
| 03/27/2008 | WO2007132164A3 Analysis of proteins |
| 03/27/2008 | WO2007122369A3 Novel tumour suppressor |
| 03/27/2008 | WO2007106800A3 In vivo induced genes of mycobacterium tuberculosis |
| 03/27/2008 | WO2007076524A3 Human anti-il-23 antibodies, compositions, methods and uses |
| 03/27/2008 | WO2007071363A3 METHODS OF USING THE CALCINEURIN A VARIANT Cnaβ1 |
| 03/27/2008 | WO2007067737A3 Methods and compositions for inhibiting hiv infection |
| 03/27/2008 | WO2007038829A8 Method of drug design |
| 03/27/2008 | WO2006056480A3 Means and methods for detecting methylated dna |
| 03/27/2008 | WO2005105984A3 Culture conditions and growth factors affecting fate determination, self-renewal and expansion of mouse spermatogonial stem cells |
| 03/27/2008 | WO2004066943A3 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin |
| 03/27/2008 | US20080077999 Using Nonhuman Animal Model, Method of Measuring Transcription Activity Method of Measuring Cell Quantity and Method of Measuring Tumor Volume |
| 03/27/2008 | US20080077375 Integrated Biosensor and Simulation System for Diagnosis and Therapy |
| 03/27/2008 | US20080077373 Spatial Profiling of Proteins Using Hydrophobic Moments |
| 03/27/2008 | US20080077372 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 03/27/2008 | US20080077331 Methods for remote characterization of an odor |
| 03/27/2008 | US20080077330 Method for detecting erroneous measurement results obtained with ion-selective electrodes |
| 03/27/2008 | US20080077329 High-throughput automated cellular injection system and method |
| 03/27/2008 | US20080077037 Selective point of care nanoprobe breath analyzer |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | US20080076835 Identifying modulator of silent information regulator 2 (Sir2) protein for use in transcriptional silencing and DNA damage repair; NAD and an acetylated histone peptide; cancer, neurodegenerative disorders, metabolic disorders, and disorders associated with apoptosis |
| 03/27/2008 | US20080076816 Non-Covalent Complexes Comprising Carbon Nanotubes |
| 03/27/2008 | US20080076727 antibody cocktails each recognizing a distinct epitope on the HMW-MAA protein; |
| 03/27/2008 | US20080076709 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 03/27/2008 | US20080076676 Novel construction of gold nanoparticle-based peptide chip, and assaying enzyme activity and inhibitor effect using secondary ion mass spectrometric analysis thereof |
| 03/27/2008 | US20080076671 Applications of Nucleic Acid Fragments |
| 03/27/2008 | US20080076670 Artificial receptors |
| 03/27/2008 | US20080076669 Method of screening by using conformation sensitive peptides |
| 03/27/2008 | US20080076190 Fluidic Indicator Device |
| 03/27/2008 | US20080076185 Apparatus comprising cyclohexylsulfamic acid and/or salts for use in detection and quantification of chlorine dioxide in foreign gas |
| 03/27/2008 | US20080076184 Visual, continuous and simultaneous measurement of solution ammonia and hydrogen ion concentration |
| 03/27/2008 | US20080076183 Macromolecular conjugate which comprises alanine, glycine and argine in c-terminal domain for use coagulation diagnostics |
| 03/27/2008 | US20080076182 Solid/liquid separation of microvolumes of blood |
| 03/27/2008 | US20080076169 Lateral flow strip assay |
| 03/27/2008 | US20080076151 Compositions for controlling hair growth |
| 03/27/2008 | US20080076148 Using presence hyaluronic acid on surface of cell as evaluative tool in screening for preferential progenitor cells |
| 03/27/2008 | US20080076146 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 03/27/2008 | US20080076145 Transgenic flies expressing tau and amyloid precursor fragment |
| 03/27/2008 | US20080076143 Microfluidic system for proteome analysis |
| 03/27/2008 | US20080076140 Using concentration of glycogen synthase kinase-3 (GSK3) as diagnostic/prognostic indicator of neurodegenerative disease |
| 03/27/2008 | US20080076139 Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cells |
| 03/27/2008 | US20080076138 Novel Pd Marker for Histone Deacetylase Inhibitor |
| 03/27/2008 | US20080076137 Bioanalytic Systems and Methods |
| 03/27/2008 | US20080076136 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement |
| 03/27/2008 | US20080076133 Method for determining polymorphism |
| 03/27/2008 | US20080076132 Using enzyme inhibitors in combination chemotherapeutic agents to enhance therapeutic outcomes associated with cell proliferative disorers |
| 03/27/2008 | US20080076130 Molecular haplotyping of genomic dna |
| 03/27/2008 | US20080076119 Which provide enhanced Raman signal; silver, gold, copper, palladium, platinum, and aluminum particles and rhodamine |
| 03/27/2008 | US20080076113 Using proteomic expression as tool in prediciting success of therapeutic regimen; bioinformatics |
| 03/27/2008 | US20080076112 Method for quantitation of collagen in tissue |
| 03/27/2008 | US20080076111 Using DNA staining agents acridine orange or propidium iodide as tools in determining concentration of mature sperm in semen; artificial insemination; animal husbandry |
| 03/27/2008 | US20080075796 Compositions and Methods for Controlling Insects |
| 03/27/2008 | US20080075782 Comprising a stabilizing polyol and a bioactive agent, wherein the composition provides quick release of the bioactive agent after administration; inhalation through the mouth; drug delivery; osteoporosis treatment |
| 03/27/2008 | US20080075741 Recombinant P. falciparum merozoite protein-1 42 vaccine |
| 03/27/2008 | US20080075736 Materials and methods for respiratory disease control in canines |
| 03/27/2008 | US20080075735 Demethylated and/or oxidized membrane DNA |
| 03/27/2008 | US20080075732 Preparation of Antigen-Presenting Human Gamma-Delta T Cells and Use in Immunotherapy |
| 03/27/2008 | US20080075725 Novel Immunointeractive Molecules and uses Thereof |
| 03/27/2008 | US20080075722 detecting the presence of a protein marker in patient sample, using a reagent which specifically binds with protein; comparing the copy number of a minimal common region; anticarcinogenic biodrugs |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |